| Plasmodium falciparum: Multidrug resistance S Rout, RK Mahapatra Chemical biology & drug design 93 (5), 737-759, 2019 | 55 | 2019 |
| In silico comparative genomics analysis of Plasmodium falciparum for the identification of putative essential genes and therapeutic candidates S Rout, DC Warhurst, M Suar, RK Mahapatra Journal of microbiological methods 109, 1-8, 2015 | 25 | 2015 |
| In silico screening of novel inhibitors of M17 Leucine Amino Peptidase (LAP) of Plasmodium vivax as therapeutic candidate S Rout, RK Mahapatra Biomedicine & Pharmacotherapy 82, 192-201, 2016 | 23 | 2016 |
| In silico analysis of plasmodium falciparum CDPK5 protein through molecular modeling, docking and dynamics S Rout, RK Mahapatra Journal of Theoretical Biology 461, 254-267, 2019 | 17 | 2019 |
| In silico study of M18 aspartyl amino peptidase (M18AAP) of Plasmodium vivax as an antimalarial drug target S Rout, RK Mahapatra Bioorganic & Medicinal Chemistry 27 (12), 2553-2571, 2019 | 13 | 2019 |
| An in silico strategy for identification of novel drug targets against Plasmodium falciparum S Rout, NP Patra, RK Mahapatra Parasitology research 116, 2539-2559, 2017 | 11 | 2017 |
| Design of Antimalarial Small Drug Molecules Against Plasmodium Species Computational and Experimental Approach S Rout Bhubaneswar, 0 | | |
David C. Warhurstemeritus professor protozoan chemotherapy, London School of Hygiene and Tropical Medicine UK在 lshtm.ac.uk 的电子邮件经过验证
